ARG59321

anti-ANGPTL4 antibody

anti-ANGPTL4 antibody for Western blot and Human

Overview

Product Description Rabbit Polyclonal antibody recognizes ANGPTL4
Tested Reactivity Hu
Predict Reactivity Ms, Rat, Hm
Tested Application WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name ANGPTL4
Antigen Species Human
Immunogen Synthetic peptide corresponding to aa. 349-367 of Human ANGPTL4. (WWFGTCSHSNLNGQYFRSI)
Conjugation Un-conjugated
Alternate Names UNQ171; NL2; pp1158; FIAF; Angiopoietin-like protein 4; TGQTL; Hepatic fibrinogen/angiopoietin-related protein; Angiopoietin-related protein 4; ARP4; PGAR; HFARP; HARP

Application Instructions

Application Suggestion
Tested Application Dilution
WB0.1 - 0.5 µg/ml
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Affinity purification with immunogen.
Buffer 0.9% NaCl, 0.2% Na2HPO4, 0.05% Thimerosal, 0.05% Sodium azide and 5% BSA.
Preservative 0.05% Thimerosal and 0.05% Sodium azide
Stabilizer 5% BSA
Concentration 0.5 mg/ml
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 51129 Human ANGPTL4

Swiss-port # Q9BY76 Human Angiopoietin-related protein 4

Gene Symbol ANGPTL4
Gene Full Name angiopoietin-like 4
Background This gene encodes a glycosylated, secreted protein containing a C-terminal fibrinogen domain. The encoded protein is induced by peroxisome proliferation activators and functions as a serum hormone that regulates glucose homeostasis, lipid metabolism, and insulin sensitivity. This protein can also act as an apoptosis survival factor for vascular endothelial cells and can prevent metastasis by inhibiting vascular growth and tumor cell invasion. The C-terminal domain may be proteolytically-cleaved from the full-length secreted protein. Decreased expression of this gene has been associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4. [provided by RefSeq, Sep 2013]
Function Protein with hypoxia-induced expression in endothelial cells. May act as a regulator of angiogenesis and modulate tumorigenesis. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. May exert a protective function on endothelial cells through an endocrine action. It is directly involved in regulating glucose homeostasis, lipid metabolism, and insulin sensitivity. In response to hypoxia, the unprocessed form of the protein accumulates in the subendothelial extracellular matrix (ECM). The matrix-associated and immobilized unprocessed form limits the formation of actin stress fibers and focal contacts in the adhering endothelial cells and inhibits their adhesion. It also decreases motility of endothelial cells and inhibits the sprouting and tube formation (By similarity). [UniProt]
Cellular Localization Secreted. Secreted, extracellular space, extracellular matrix. Note=The unprocessed form interacts with the extracellular matrix. This may constitute a dynamic reservoir, a regulatory mechanism of the bioavailability of ANGPTL4 (By similarity). [UniProt]
Calculated MW 45 kDa
PTM N-glycosylated. [UniProt]

Images (1) Click the Picture to Zoom In

  • ARG59321 anti-ANGPTL4 antibody WB image

    Western blot: 50 ug of Human placenta, 40 ug of SMMC-7721 and 40 ug of HeLa whole cell lysates stained with ARG59321 anti-ANGPTL4 antibody at 0.5 ug/ml dilution.